Exagen Inc. (XGN) Reports Q2 Loss, Tops Revenue Estimates

This article was originally published on Nasdaq

Exagen Inc. (XGN) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.48. This compares to loss of $0.78 per share a year ago. These figures are adjusted for non-recurring items.